Samil Pharmaceutical Co., Ltd.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Public
- Established
- 1946-01-01
- Employees
- 568
- Market Cap
- -
- Website
- http://www.samil-pharm.com
To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Diseases of the Circulatory SystemEssential Hypertension
- Interventions
- First Posted Date
- 2015-10-19
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- Samil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02579356
- Locations
- π°π·
Chonbuk National University Hospital, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath